Status | Study |
Recruiting |
Study Name: Alterations in Muscle's Functional Characteristics After Parathyroid Surgery for Primary Hyperparathyroidism. Condition: Hyperparathyroidism, Primary Parathyroidectomy Date: 2017-03-03 |
Recruiting |
Study Name: Percent Change in Baseline Bone Mineral Density (BMD) After Parathyroidectomy in Patients With Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2017-02-10 Interventions: Other: Retrospective Data Review Retrospective, uncontrolled pre- and post-test design in a case series |
Recruiting |
Study Name: Evaluating Alternative Medical Therapies in Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2015-08-14 Interventions: Drug: eplerenone eplerenone, t |
Completed |
Study Name: Bone Architectural Parameters in Postmenopausal Women Affected With Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Bone Disease Date: 2015-04-27 Interventions: Device: HR-pQCT HR-pQCT to evaluate cortical and trabecular bone |
Completed |
Study Name: Efficacy of Cinacalcet in the Control of Primary Hyperparathyroidism Condition: Hyperparathyroidism, Primary Osteoporosis Date: 2015-04-08 Interventions: Drug: cinacalcet During Phase |
Recruiting |
Study Name: Primary Hyperparathyroidism: Short-term Calcimimetics Treatment - Relevance for Parathyroid Surgery Decisions? Condition: Primary Hyperparathyroidism Date: 2014-08-17 Interventions: Drug: Cinacalcet Cinacalcet, M |
Recruiting |
Study Name: EC17 for Intraoperative Imaging for Parathyroidectomy Condition: Primary Hyperparathyroidism Date: 2013-11-21 Interventions: Drug: EC17 Other Name: Folate- FITC |
Completed |
Study Name: OPG/Soluble RANKL (sRANKL) and Bone Mineral Density in Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2013-06-21 Interventions: Drug: Sedron (alendronate) Oth |
Completed |
Study Name: Evaluation of Non Specific Symptoms and Quality of Life Before and After Surgery for Mild Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2012-10-24 |
Completed |
Study Name: Denosumab in Primary Hyperparathyroidism Condition: Primary Hyperparathyroidism Date: 2012-03-16 Interventions: Drug: Denosumab |